NCT01904981View on ClinicalTrials.gov

Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm and Hypertension (BASE Trial)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 18, 2017

Study Completion Date

April 18, 2017

Conditions

Small Abdominal Aortic Aneurysm

Interventions

DRUG

Beta-blocker-Atenolol 50mg, PO(peroral), Once daily

DRUG

Angiotensin receptor blocker-Valsartan 80mg, PO(peroral), Once daily

Trial Locations (1)

120-752

Severance Hospital, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER

NCT01904981 - Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm and Hypertension (BASE Trial) | Biotech Hunter | Biotech Hunter